James Hennen - Vascular Solutions CFO and Sr. VP of Fin.
CFO
Mr. James Hennen is Chief Financial Officer and Senior Vice President Finance, Corporationrationrate Secretary of Vascular Solutions, Inc. James Hennen has served as our Chief Financial Officer since January 2004. Mr. Hennen served as our Controller Director of Finance from February 2002 through December 2003. Prior to joining us, Mr. Hennen served in various accounting positions, most recently as International Controller with WAMNET, Inc., a globally networked information technology company for media transfer, where he worked from December 1997 through February 2002. From October 1995 through December 1997, Mr. Hennen was an auditor for Ernst Young, LLP. Mr. Hennen is a Certified Public Accountant . since 2012.
| Age | 42 |
| Tenure | 12 years |
| Phone | 877 656-4251 |
| Web | www.vasc.com |
Vascular Solutions Management Efficiency
The company has return on total asset (ROA) of 0.13 % which means that it generated a profit of $0.13 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.15 %, meaning that it created $0.15 on every $100 dollars invested by stockholders. Vascular Solutions' management efficiency ratios could be used to measure how well Vascular Solutions manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 867 K in liabilities with Debt to Equity (D/E) ratio of 0.13, which may suggest the company is not taking enough advantage from borrowing. Vascular Solutions has a current ratio of 6.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Vascular Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Vascular Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vascular Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vascular to invest in growth at high rates of return. When we think about Vascular Solutions' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 6 records | CFO Age | ||
| Deepak Ahuja | Tesla Inc | 53 | |
| Deborah OConnor | Acco Brands | 61 | |
| Robert Christensen | PACCAR Inc | 59 | |
| Jason Wheeler | Tesla Inc | 41 | |
| Brian Meyers | Lincoln Educational Services | 48 | |
| Zachary Kirkhorn | Tesla Inc | 39 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.13 |
Vascular Solutions Leadership Team
Elected by the shareholders, the Vascular Solutions' board of directors comprises two types of representatives: Vascular Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vascular. The board's role is to monitor Vascular Solutions' management team and ensure that shareholders' interests are well served. Vascular Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vascular Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Erb, Independent Chairman of the Board | ||
| Brett Demchuk, Vice President - Product Quality | ||
| Phillip Nalbone, Vice President - Corporate Development | ||
| Brent Binkowski, Sr. VP of Operations | ||
| William Rutstein, Sr. VP of International Sales | ||
| Richard Kramp, Independent Director | ||
| Jorge Saucedo, Independent Director | ||
| Jonathan Hammond, Vice President - Manufacturing Engineering | ||
| Charmaine Sutton, Sr. VP of Operations | ||
| Chad Kugler, Sr. VP of RandD | ||
| Martin Emerson, Independent Director | ||
| Richard Nigon, Independent Director | ||
| James Hennen, CFO and Sr. VP of Fin. | ||
| Susan Christian, Vice President - Sales Operations | ||
| Paul OConnell, Independent Director | ||
| Carrie Powers, VP of Marketing | ||
| Howard Root, Co-Founder, CEO and Director |
Vascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vascular Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 9.41 % | |||
| Current Valuation | 937.53 M | |||
| Shares Outstanding | 17.57 M | |||
| Shares Owned By Insiders | 3.98 % | |||
| Shares Owned By Institutions | 73.40 % | |||
| Number Of Shares Shorted | 982.09 K | |||
| Price To Earning | 81.18 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vascular Solutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vascular Solutions' short interest history, or implied volatility extrapolated from Vascular Solutions options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Solutions' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |